Ameritas Investment Partners’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.76K | Hold |
20
| – | – | ﹤0.01% | 3029 |
|
|
2025
Q4 | $3.79K | Hold |
20
| – | – | ﹤0.01% | 3057 |
|
|
2025
Q3 | $3.31K | Sell |
20
-10
| -33% | -$1.63K | ﹤0.01% | 3090 |
|
|
2025
Q2 | $4.6K | Hold |
30
| – | – | ﹤0.01% | 3115 |
|
|
2025
Q1 | $4.72K | Hold |
30
| – | – | ﹤0.01% | 2984 |
|
|
2024
Q4 | $4.71K | Hold |
30
| – | – | ﹤0.01% | 3032 |
|
|
2024
Q3 | $5.32K | Hold |
30
| – | – | ﹤0.01% | 3032 |
|
|
2024
Q2 | $5.05K | Hold |
30
| – | – | ﹤0.01% | 3031 |
|
|
2024
Q1 | $4.99K | Hold |
30
| – | – | ﹤0.01% | 2949 |
|
|
2023
Q4 | $4.96K | Hold |
30
| – | – | ﹤0.01% | 2970 |
|
|
2023
Q3 | $4.67K | Hold |
30
| – | – | ﹤0.01% | 3002 |
|
|
2023
Q2 | $4.68K | Hold |
30
| – | – | ﹤0.01% | 3034 |
|
|
2023
Q1 | $4.86K | Hold |
30
| – | – | ﹤0.01% | 2866 |
|
|
2022
Q4 | $4.79K | Hold |
30
| – | – | ﹤0.01% | 2927 |
|
|
2022
Q3 | $4K | Buy |
30
+10
| +50% | +$1.51K | ﹤0.01% | 2935 |
|
|
2022
Q2 | $2K | Hold |
20
| – | – | ﹤0.01% | 3027 |
|
|
2022
Q1 | $3K | Hold |
20
| – | – | ﹤0.01% | 3023 |
|
|
2021
Q4 | $3K | Hold |
20
| – | – | ﹤0.01% | 3073 |
|
|
2021
Q3 | $4K | Hold |
20
| – | – | ﹤0.01% | 3042 |
|
|
2021
Q2 | $4K | Hold |
20
| – | – | ﹤0.01% | 3003 |
|
|
2021
Q1 | $3K | Hold |
20
| – | – | ﹤0.01% | 3052 |
|
|
2020
Q4 | $3K | Hold |
20
| – | – | ﹤0.01% | 3020 |
|
|
2020
Q3 | $3K | Hold |
20
| – | – | ﹤0.01% | 3037 |
|
|
2020
Q2 | $3K | Hold |
20
| – | – | ﹤0.01% | 3016 |
|
|
2020
Q1 | $2K | Hold |
20
| – | – | ﹤0.01% | 2954 |
|
|
2019
Q4 | $2K | Hold |
20
| – | – | ﹤0.01% | 2966 |
|
|
2019
Q3 | $2K | Hold |
20
| – | – | ﹤0.01% | 3013 |
|
|
2019
Q2 | $2K | Hold |
20
| – | – | ﹤0.01% | 3010 |
|
|
2019
Q1 | $2K | Hold |
20
| – | – | ﹤0.01% | 2942 |
|
|
2018
Q4 | $2K | Hold |
20
| – | – | ﹤0.01% | 2943 |
|
|
2018
Q3 | $2K | Hold |
20
| – | – | ﹤0.01% | 3001 |
|
|
2018
Q2 | $2K | Hold |
20
| – | – | ﹤0.01% | 2979 |
|
|
2018
Q1 | $2K | Sell |
20
-30
| -60% | -$3.77K | ﹤0.01% | 2920 |
|
|
2017
Q4 | $29K | Hold |
50
| – | – | ﹤0.01% | 2235 |
|
|
2017
Q3 | $6K | Hold |
50
| – | – | ﹤0.01% | 2890 |
|
|
2017
Q2 | $6K | Hold |
50
| – | – | ﹤0.01% | 2909 |
|
|
2017
Q1 | $5K | Hold |
50
| – | – | ﹤0.01% | 2831 |
|
|
2016
Q4 | $5K | Sell |
50
-80
| -62% | -$8.7K | ﹤0.01% | 1217 |
|
|
2016
Q3 | $14K | Hold |
130
| – | – | ﹤0.01% | 1180 |
|
|
2016
Q2 | $13K | Hold |
130
| – | – | ﹤0.01% | 1111 |
|
|
2016
Q1 | $13K | Hold |
130
| – | – | ﹤0.01% | 1111 |
|
|
2015
Q4 | $16K | Hold |
130
| – | – | ﹤0.01% | 1097 |
|
|
2015
Q3 | $14K | Hold |
130
| – | – | ﹤0.01% | 1057 |
|
|
2015
Q2 | $17K | Hold |
130
| – | – | ﹤0.01% | 1101 |
|
|
2015
Q1 | $16K | Hold |
130
| – | – | ﹤0.01% | 1146 |
|
|
2014
Q4 | $14K | Buy |
+130
| New | +$14.6K | ﹤0.01% | 1133 |
|
Other funds holding BBH
MIM
CCA
BFG
Ameritas Investment Partners's BBH Position: Q1 2026 in Review
Ameritas Investment Partners held its VanEck Biotech ETF (BBH) position steady in Q1 2026 at 20 shares worth $3.76K. The position accounts for ﹤0.01% of the portfolio, ranked #3029.
Ameritas Investment Partners first reported a position in BBH in Q4 2014 and has held it in 46 quarters since. The position peaked at $29K in Q4 2017. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.
- Ameritas Investment Partners held 20 shares of VanEck Biotech ETF worth $3.76K as of Q1 2026.
- Ameritas Investment Partners left its VanEck Biotech ETF share count unchanged in Q1 2026.
- VanEck Biotech ETF made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #3029 holding.
- Ameritas Investment Partners first reported a position in VanEck Biotech ETF in Q4 2014 and has held it in 46 quarters since.
- Ameritas Investment Partners's VanEck Biotech ETF position peaked at $29K in Q4 2017.
- 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.
Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.